Full-Service CRO
Aixial Group is a well-established, full-service CRO with experienced people and advanced technology for clinical data management.
Providing efficient CRO solutions for all your trial needs
We help you keep everything on track and on budget! We specialise in applying both expertise and technology to deliver well-managed clinical trials solutions in oncology, rare diseases, cell and gene therapy, and other specialty therapeutics.
Comprehensive Clinical Trial Support for Biotech and Pharma
At the heart of our services is a commitment to supporting biotech and pharma companies through every phase of clinical development. From strategic planning and IND submissions to protocol design, feasibility, and trial start-up, we bring precision and agility to each step. Our integrated approach spans clinical operations, monitoring, medical and safety oversight, pharmacovigilance (PVG), and advanced data science and analytics, delivering clarity in the face of complexity, and value at every milestone.
An expert early-phase team
With our first-hand knowledge and expertise applied, we focus on safety while placing careful attention on each dose and patient need.
Understanding that flexibility and speed are also vital to these stages of clinical development, our resident early-phase oncology and rare disease experts can build both detail and flexibility into program and project planning to maximise success, all while mitigating potential issues with dosing protocols and adverse events.
Phase II / III CRO Services: dedicated resources for helping you reach your goals faster.
Through our 30+ years of experience and 15+ years of design and delivery of virtual and patient-centric trials, we’ve developed processes to support even the most complicated patient identification, product manufacture, and dose administration timeframes. Your studies are safeguarded and enhanced through Aixial Group.
Decentralised Trials: speed without compromising patients or quality.
In today’s world, Decentralised Trials (DCT) or virtual clinical trials are not a new concept. Our industry has made the shift to full implementation, and designing hybrid protocols that support trial continuity with a more patient-centric approach is the norm. However, more complexity is now involved with even more intensive data capture. Our unique approach and experience give us the ability to implement agile methods and actionable accelerated strategies that help reduce workloads and patient burden, and gain speed to market.
How can we support your next project?
Whether you’re looking for a protocol review or a proposal,
simply reach out to us by filling our request for proposal.
Insights
Other ways we support you
Helping you succeed in your project